The most globally prevalent cancers include breast, lung, bowel and prostate cancers
Category: Cancer
Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020
The installation will double the capacity of cancer genomic testing using robotic automation
The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines
The findings could potentially lead to new therapies and could stop the growth of cancers
Around three million people in the UK were estimated to be living with cancer in 2022
The genetic condition affects one in 279 people in England and significantly increases cancer risk
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
The gamma treatment also shows potential for treating patients living with neurological diseases